Protecting the brain after cardiac arrest

By Jan Jarvis

Mallet_web

A new treatment identified by UNT Health Science researchers may protect the brain from irreversible brain damage caused by cardiac arrest.

The discovery, published in the May issue of Experimental Biology and Medicine, could offer hope to the more than 500,000 people in the United States who suffer a cardiac arrest each year. Currently there are few treatments available to help these patients.

The brain consumes enormous amounts of metabolic energy and is dependent on its blood supply to deliver energy-yielding fuels and oxygen. When the brain’s blood supply is interrupted, such as during a cardiac arrest, the brain rapidly depletes its energy reserves and toxic metabolites accumulate.

This leads to damage in the molecular components of the brain’s cells, including proteins. As a result, only 8 percent of those who suffer a cardiac arrest outside the hospital survive with brain function intact, said Robert Mallet, PhD, Professor, Institute for Cardiovascular and Metabolic Disease.

“Cardiac arrest is devastating because it severely injures the brain,” Dr. Mallet said. “Moreover, those who are fortunate enough to survive cardiac arrest may be at increased risk of developing senile dementia.”

Cardiac arrest triggers the production of the metabolite methylglyoxal, a byproduct of sugar metabolism that damages proteins and may cause permanent impairment of brain function. In the lab, a research team led by Dr. Mallet found that glyoxalase and other protective enzymes were inactivated following cardiac arrest and CPR, weakening the brain’s natural defenses against methylglyoxal and other toxins.

But giving patients an intravenous infusion of an energy fuel and antioxidant called pyruvate may restore these defenses and preserve functional brain proteins, according to the study. Pyruvate is a natural metabolite that protects the brain against methylglyoxal when given in a timely fashion, Dr. Mallet said.

“Pyruvate could be an ideal brain protectant because it is effective in humans, is chemically stable and has no adverse side effects,” Dr. Mallet said.

Recent News

Brock Hoffman 08
  • Community
|Nov 24, 2025

Cowboys’ Brock Hoffman honors wife’s UNT Health PA program through NFL’s ‘My Cause My Cleats’ initiative

When Dallas Cowboys offensive lineman Brock Hoffman takes the field for warm-ups before Sunday’s game against the Eagles, his cleats will carry a message far bigger than football. As part of the NFL’s annual “My Cause My Cleats” campaign, Hoffman has chosen to honor his wife, Abbey Montoy...
Ab97cf99 8f28 4b5f 8ad9 F54ee30a0022
  • Community
|Nov 14, 2025

UNT Health welcomes new research director to North Texas Eye Research Institute

A former scientific project and alliance manager at the Allen Institute for Brain Science in Seattle recently was named the new director of research for UNT Health Fort Worth’s North Texas Eye Research Institute, guiding its next phase of growth and innovation. David Vumbaco, Ph.D., started h...
Img 3423
  • Community
|Nov 14, 2025

UNT Health’s marketing and communications initiatives earn top honors at PRSA Worthy Awards

UNT Health Fort Worth’s marketing and communications staff members were recognized among the region’s best at the 2025 PRSA Worthy Awards Gala, earning multiple honors for creative storytelling and strategic impact. Presented on Nov. 7 by the Greater Fort Worth Chapter of the Public Relations S...
Img 3670
  • Community
|Nov 13, 2025

Report shows attending TCOM the most affordable in the nation

A recent report published by the American Association of Colleges of Osteopathic Medicine showed the cost of producing some of the top primary care physicians in the nation might surprise you, as UNT Health at Fort Worth’s Texas College of Osteopathic Medicine was among the most affordable in the ...